This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

About this trial

Last updated 2 years ago

Study ID

CARYSMA Registry Study 466/16

Status

Active, not recruiting

Type

Observational [Patient Registry]

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 8 years ago

What is this trial about?

In this prospective longitudinal observational investigator-led single centre cohort study we will include patients undergoing cardio-CT for clinical reasons, to evaluate the role of cardio-CT terms of its diagnostic and prognostic value, as well as risk-benefit ratio. Particular aims include: 1. To determine the prevalence of CAD for age, gender, ethnicity relative to established risk models 2. To determine associations between CAD severity and plaque type and: 1. with traditional risk factors (arterial hypertension, diabetes, hypercholesterolemia, smoking) 2. blood markers of increased cardiovascular risk 3. To determine predictive associations of between CAD with outcome (endpoint definitions in appendix) 4. To determine the risk-benefit ratio (number of subsequent interventions, complications, radiation exposure, late onset of cancer diseases, etc).

What are the participation requirements?

Yes

Inclusion Criteria

1. Adults (=/>18 years of age)

2. Able to provide informed consent

3. Clinical indication for cardio-CT in line with the latest clinical guidelines

No

Exclusion Criteria

1. standard contraindications to CT (in line with local roles and guidelines - please see Appendix)

2. known allergy to iodinated contrast agent

3. suspected acute kidney injury

4. unstable hemodynamic status or arrhythmias

5. suspected acute coronary syndrome

6. manifest thyrotoxicosis

Locations

Location

Status